Last update 22 Feb 2025

Universal CD19 CAR-T cells(The Children's Hospital of Zhejiang University School of Medicine)

Overview

Basic Info

Drug Type
Universal CAR-T
Synonyms-
Target
CD19
Mechanism
CD19 modulators(B-lymphocyte antigen CD19 modulators)
Therapeutic Areas
Immune System DiseasesSkin and Musculoskeletal DiseasesOther Diseases
Active Indication
Scleroderma, Systemic
Inactive Indication-
Originator Organization
The Children's Hospital of Zhejiang University School of Medicine
Active Organization
The Children's Hospital of Zhejiang University School of Medicine
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Universal CD19 CAR-T cells(The Children's Hospital of Zhejiang University School of Medicine)
NCT06792344
/ RecruitingPhase 1IIT
Clinical Study of CD19 Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Refractory Systemic Sclerosis
NCT06691152
/ RecruitingPhase 1IIT
Efficacy and Safety Study of CD19 Universal CAR T Cells in Refractory Systemic Lupus Erythematosus
100 Clinical Results associated with Universal CD19 CAR-T cells(The Children's Hospital of Zhejiang University School of Medicine)
Login to view more data
100 Translational Medicine associated with Universal CD19 CAR-T cells(The Children's Hospital of Zhejiang University School of Medicine)
Login to view more data
100 Patents (Medical) associated with Universal CD19 CAR-T cells(The Children's Hospital of Zhejiang University School of Medicine)
Login to view more data
100 Deals associated with Universal CD19 CAR-T cells(The Children's Hospital of Zhejiang University School of Medicine)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Scleroderma, SystemicPhase 1
CN
The Children's Hospital of Zhejiang University School of Medicine
15 Dec 2024
Scleroderma, SystemicPhase 1
CX
The Children's Hospital of Zhejiang University School of Medicine
15 Dec 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free